Jeffrey M. Liebmann, MD

Jeffrey M. Liebmann, MD

Professor of Ophthalmology, Glaucoma Service Director, and Vice Chari of the Department of Ophthalmology, Columbia University

Shirlee and Bernard Brown Professor of Ophthalmology
Vice-Chair, Department of Ophthalmology
Director, Glaucoma Service
Edward S. Harkness Eye Institute
Columbia University Medical Center

Dr. Jeffrey M. Liebmann graduated from Boston University School of Medicine, completed his ophthalmology residency at the State University of New York/Downstate Medical Center, and his glaucoma fellowship at the New York Eye and Ear Infirmary. Dr. Liebmann serves as Shirlee and Bernard Brown Professor, Vice-Chair, and Director of the Glaucoma Division of the Department Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, and American College of Surgeons. Dr. Liebmann is currently Editor-in-Chief of Journal of Glaucoma, a member of the Board of Governors of the World Glaucoma Association and Board of Directors of The Glaucoma Foundation and Secretary-Treasurer of the New York Glaucoma Society and is a past-President of the World Glaucoma Association and the American Glaucoma Society. Dr. Liebmann has served as President of the New York Society for Clinical Ophthalmology and was co-founder of the New York Glaucoma Research Institute, the American Glaucoma Society Foundation and ASCRS Glaucoma Day.

In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Liebmann is Principal Investigator for the African Descent and Glaucoma Evaluation Study (ADAGES) and Ocular Hypertension Treatment Study (OHTS III) at Columbia University and is the author and/or co-author of more than 1000 medical and scientific papers, book chapters, and abstracts. He has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include the causes of glaucoma, glaucoma progression, glaucoma surgery, ocular imaging, and neuroprotection.